Q1 2023 Results slide image

Q1 2023 Results

Company overview Financial review Conclusions Appendix References Vas Narasimhan, M.D. Chief Executive Officer 29 Investor Relations | Q1 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation